NCT03473522

Brief Summary

Parkinson's disease is a progressive, degenerative neurological disease associated with profound changes in the quality of life of its survivors. Therapeutic exercises are widely employed in the attempt to delay or minimize disease progression, characterized by significant motor and sensory deficits. Recent evidence has demonstrated the potential use of transcranial direct current stimulation (TDCs) as a complement to therapeutic exercises. However, few studies have investigated the effects of TDCs combined with therapeutic exercises in patients with Parkinson's disease. This study aims to investigate the effect of TDCs combined with therapeutic exercises in people with Parkinson's disease. Thirty patients will be randomized into two distinct groups to receive either TDCs(anodal) + therapeutic exercises or TDCs (sham) + therapeutic exercises for 24 sessions over a five-week period. The primary clinical outcome (balance) and secondary outcomes (functional capacity, quality of life and perception of overall effect) will be collected before treatment after two and five weeks at month 3 and month 6 after randomization. The data will be collected by a blind examiner to the treatment allocation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2 parkinson-disease

Timeline
Completed

Started Feb 2018

Typical duration for phase_2 parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

February 7, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 22, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2021

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

1.8 years

First QC Date

February 7, 2018

Last Update Submit

April 30, 2021

Conditions

Keywords

Transcranial Direct Current Stimulationtherapeutic exercisesParkinson

Outcome Measures

Primary Outcomes (1)

  • Change From balance

    Balance will be evaluated using a force plate to record center of pressure displacement (COP) in antero-posterior (AP) and Mediolateral (ML) axes in centimeters. Other variables such as area (cm²), speed AP and ML(cm/s), frequency (Hz) and Entropy (no unit) will be derived from COP displacement.

    8 weeks after randomization

Secondary Outcomes (6)

  • Change From balance

    3 and 6 months after randomization

  • Change From Unified Parkinson´s Disease Rating Scale

    8 weeks, 3 and 6 months after randomization

  • Change From Parkinson Disease Quality of Life

    8 weeks, 3 and 6 months after randomization

  • Change in the perception scale of the overall effect

    8 weeks, 3 and 6 months after randomization

  • Maximal Isometric Voluntary Contraction

    8 weeks, 3 and 6 months after randomization

  • +1 more secondary outcomes

Other Outcomes (1)

  • Geriatric Depression Scale (GDS)

    8 weeks, 3 and 6 months after randomization

Study Arms (2)

anodal tDCS +Exercise Therapy

EXPERIMENTAL

Anodal tDCS (2mA of intensity, for twenty minutes) over the motor cortex representation of trunk and lower limbs. Immediately after tDCS application all the patients will participate in an exercise therapy protocol involving balance control, strength,

Device: tDCSBehavioral: Exercise Therapy

Sham tDCS+ Exercise Therapy

SHAM COMPARATOR

Anodal tDCS (2mA of intensity, for twenty minutes but thirdy seconds ON) over the motor cortex representation of trunk and lower limbs.

Device: tDCSBehavioral: Exercise Therapy

Interventions

tDCSDEVICE

Transcranial direct current stimulation is a modulation technique of neuronal excitability which has very promising results in Parkinson's disease. In addition to the possibility of increasing the excitability of areas to tDCS, it can also facilitate the execution of the exercises by increasing the excitability of the primary motor cortex and changing the recruitment strategies of the motor units.

Also known as: non invasive brain stimulation
Sham tDCS+ Exercise Therapyanodal tDCS +Exercise Therapy

Therapeutic exercises will be based on the literature (O'Sullivan and Schmitz 2004, Klamroth et al 2016, Reynolds et al., 2016, Pérez et al 2016, Smania et al., 2010, Pastor et al., 1993, Traub et al., 1980, Schoneburg et al., 2013) Each session will be divided into warm-up exercises; balance and relaxation, with a duration of 50 minutes and a frequency of 3 times a week. Training progresses and intensifies every two weeks. The subjects will perform five repeated movements of each exercise, evolving according to the condition of each patient (according to the Hoehn and Yahr staging scale).

Also known as: Physiotherapy
Sham tDCS+ Exercise Therapyanodal tDCS +Exercise Therapy

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • medical diagnosis of idiopathic Parkinson's disease present for at least 12 months,
  • spontaneous demand for treatment,
  • in clinical follow-up and pharmacological treatment by a responsible physician,
  • Parkinson's classification of 1.5-3 according to the Hoehn and Yahr scale,
  • absence of cardiovascular diseases and musculoskeletal,
  • signing of the free and informed consent form.

You may not qualify if:

  • Use any associated orthopedic device to aid gait or balance control,
  • signs of severe dementia (evaluated by the Mini-Mental State Examination - MMSE),
  • diagnosis of other neurological disorders (including those of central and peripheral nature)
  • previous treatment with tDCS,
  • medical diagnosis of psychiatric illnesses with the use of centrally acting medications (depressants)
  • the use of pacemakers or other implanted devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal do Piauí

Parnaíba, Piauí, 64202020, Brazil

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Transcranial Direct Current StimulationExercise TherapyPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesRehabilitationAftercareContinuity of Patient CarePatient Care

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
double-blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized, double-blind, sham-controlled, clinical trial involving two types of intervention: (1) Physical therapy + active tDCS; (2) Physical therapy + sham tDCS.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Full Professor of Physical Therapy Department

Study Record Dates

First Submitted

February 7, 2018

First Posted

March 22, 2018

Study Start

February 1, 2018

Primary Completion

December 1, 2019

Study Completion

January 15, 2021

Last Updated

May 3, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations